APOA1 and nasopharyngeal carcinoma: This is believed to be the first large cohort study to evaluate the prognostic significance of serum biomakers of lipid metabolism including triglyceride, cholesterol, HDL-C, LDL-C, ApoA-I, and Apo-B in non-metastatic NPC patients.